Pylopass™ -- An inactivated probiotic to reduce the risk of gastritis and ulcers.

Detalles Bibliográficos
Publicado en:Wellness Foods & Supplements Vol. 17; no. 1; pp. 44 - 47
Formato: pictorial tables/charts Journal Article
Publicado: Dr. Harnisch Verlagsgesellschaft GmbH Apr/May2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=122914433&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 122914433
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23648104
        MU2S
      jtl: Wellness Foods & Supplements
      issn: 23648104
      maglogo: N
    pubinfo:
      dt: Apr/May2017
      vid: 17
      iid: 1
      pid: 35007
      pub: Dr. Harnisch Verlagsgesellschaft GmbH
    artinfo:
      ui:
        122914433
        122914433
        122914433
        122914433
      ppf: 44
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Pylopass™ -- An inactivated probiotic to reduce the risk of gastritis and ulcers.
      aug:
      sug:
        subj:
          Probiotics Therapeutic Use
          Gastritis Prevention and Control
          Peptic Ulcer Prevention and Control
          Helicobacter Infections Prevention and Control
          Lactobacillus
          Dietary Supplementation
      pubtype: Trade Publication
      doctype:
        pictorial
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N